86 related articles for article (PubMed ID: 11574425)
1. A major gene effect on fasting insulin and insulin sensitivity in familial combined hyperlipidemia.
Pihlajamäki J; Austin M; Edwards K; Laakso M
Diabetes; 2001 Oct; 50(10):2396-401. PubMed ID: 11574425
[TBL] [Abstract][Full Text] [Related]
2. The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia.
Pihlajamäki J; Miettinen R; Valve R; Karjalainen L; Mykkänen L; Kuusisto J; Deeb S; Auwerx J; Laakso M
Atherosclerosis; 2000 Aug; 151(2):567-74. PubMed ID: 10924736
[TBL] [Abstract][Full Text] [Related]
3. G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia.
Pihlajamäki J; Karjalainen L; Karhapää P; Vauhkonen I; Taskinen MR; Deeb SS; Laakso M
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1789-95. PubMed ID: 10894818
[TBL] [Abstract][Full Text] [Related]
4. Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patients.
Pihlajamäki J; Karjalainen L; Karhapää P; Vauhkonen I; Laakso M
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):164-70. PubMed ID: 10634813
[TBL] [Abstract][Full Text] [Related]
5. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia.
Pihlajamäki J; Rissanen J; Heikkinen S; Karjalainen L; Laakso M
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1039-44. PubMed ID: 9194752
[TBL] [Abstract][Full Text] [Related]
6. Impaired insulin-stimulated glucose oxidation and free fatty acid suppression in patients with familial combined hyperlipidemia: a precursor defect for dyslipidemia?
Karjalainen L; Pihlajamäki J; Karhapää P; Laakso M
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1548-53. PubMed ID: 9763525
[TBL] [Abstract][Full Text] [Related]
7. The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance.
Pihlajamäki J; Valve R; Karjalainen L; Karhapää P; Vauhkonen I; Laakso M
Eur J Clin Invest; 2001 Apr; 31(4):302-8. PubMed ID: 11298776
[TBL] [Abstract][Full Text] [Related]
8. Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus.
van der Kallen CJ; Voors-Pette C; Bouwman FG; Keizer HA; Lu JY; van de Hulst RR; Bianchi R; Janssen MJ; Keulen ET; Boeckx WD; Rotter JI; de Bruin TW
Atherosclerosis; 2002 Oct; 164(2):337-46. PubMed ID: 12204806
[TBL] [Abstract][Full Text] [Related]
9. [Genetic factors in familial combined hyperlipidemia and insulin resistance syndrome associated with dyslipidemia].
Moulin P
Ann Endocrinol (Paris); 1997; 58(4):287-91. PubMed ID: 9436476
[TBL] [Abstract][Full Text] [Related]
10. Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia.
Jarvik GP; Beaty TH; Gallagher PR; Coates PM; Cortner JA
Genet Epidemiol; 1993; 10(4):257-70. PubMed ID: 8224806
[TBL] [Abstract][Full Text] [Related]
11. Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment.
Arca M; Cambuli VM; Montali A; Sentinelli F; Filippi E; Campagna F; Quagliarini F; Antonini R; Romeo S; Baroni MG
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):660-6. PubMed ID: 19632099
[TBL] [Abstract][Full Text] [Related]
12. Evidence of pleiotropic loci for fasting insulin, total fat mass, and abdominal visceral fat in a sedentary population: the HERITAGE family study.
Hong Y; Després JP; Rice T; Nadeau A; Province MA; Gagnon J; Leon AS; Skinner JS; Wilmore JH; Bouchard C; Rao DC
Obes Res; 2000 Mar; 8(2):151-9. PubMed ID: 10757201
[TBL] [Abstract][Full Text] [Related]
13. Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype.
Jarvik GP; Brunzell JD; Austin MA; Krauss RM; Motulsky AG; Wijsman E
Arterioscler Thromb; 1994 Nov; 14(11):1687-94. PubMed ID: 7947591
[TBL] [Abstract][Full Text] [Related]
14. Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Vermeulen VM; de Bruin TW
Mol Genet Metab; 2003 Nov; 80(3):296-301. PubMed ID: 14680975
[TBL] [Abstract][Full Text] [Related]
15. In vivo modulation of plasma free fatty acids in patients with familial combined hyperlipidemia using lipid-lowering medication.
Meijssen S; Derksen RJ; Bilecen S; Erkelens DW; Cabezas MC
J Clin Endocrinol Metab; 2002 Apr; 87(4):1576-80. PubMed ID: 11932285
[TBL] [Abstract][Full Text] [Related]
16. Familial dyslipidemic hypertension syndrome: familial combined hyperlipidemia, and the role of abdominal fat mass.
Keulen ET; Voors-Pette C; de Bruin TW
Am J Hypertens; 2001 Apr; 14(4 Pt 1):357-63. PubMed ID: 11336182
[TBL] [Abstract][Full Text] [Related]
17. Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia.
Aitman TJ; Godsland IF; Farren B; Crook D; Wong HJ; Scott J
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):748-54. PubMed ID: 9108790
[TBL] [Abstract][Full Text] [Related]
18. Evidence of a major locus for lipoprotein lipase (LPL) activity in addition to a pleiotropic locus for both LPL and fasting insulin: results from the HERITAGE Family Study.
Hong Y; Rice T; Després JP; Gagnon J; Nadeau A; Bergeron J; Pérusse L; Bouchard C; Leon AS; Skinner JS; Wilmore JH; Rao DC
Atherosclerosis; 1999 Jun; 144(2):393-401. PubMed ID: 10407500
[TBL] [Abstract][Full Text] [Related]
19. Novel genes for familial combined hyperlipidemia.
Aouizerat BE; Allayee H; Bodnar J; Krass KL; Peltonen L; de Bruin TW; Rotter JI; Lusis AJ
Curr Opin Lipidol; 1999 Apr; 10(2):113-22. PubMed ID: 10327279
[TBL] [Abstract][Full Text] [Related]
20. Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.
Geurts JM; Janssen RG; van Greevenbroek MM; van der Kallen CJ; Cantor RM; Bu X; Aouizerat BE; Allayee H; Rotter JI; de Bruin TW
Hum Mol Genet; 2000 Sep; 9(14):2067-74. PubMed ID: 10958645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
